RIZZA MACAS: Open Payments
NPI 1578074688 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 46 payments from 16 companies in 2025. Trend: 2023 $1,368 · 2024 $1,662 · 2025 $1,709
Food & beverage: $1,414Education: $295
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $354 |
| AstraZeneca Pharmaceuticals LP | 6 | $291 |
| SOBI, INC | 7 | $256 |
| Syndax Pharmaceuticals, Inc. | 5 | $160 |
| Incyte Corporation | 4 | $115 |
| Novartis Pharmaceuticals Corporation | 3 | $94 |
| Lilly USA, LLC | 3 | $75 |
| GlaxoSmithKline, LLC. | 1 | $73 |
| Teleflex LLC | 2 | $68 |
| Merck Sharp & Dohme LLC | 2 | $62 |
Products named: CALQUENCE, Cresemba, Vonjo, Doptelet, SCEMBLIX, JAKAFI, JAYPIRCA, OJJAARA.
Industry payments across TX — which companies pay providers there.
